NCT06936202

Brief Summary

Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

April 15, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

April 12, 2025

Last Update Submit

August 14, 2025

Conditions

Keywords

spirulinadepressionmental acuity

Outcome Measures

Primary Outcomes (2)

  • POMS (profile of mood states questionnaire)

    A validated measure consisting of 65 brief phrases, asking how they have personally felt over the last week, including today. The participants were asked to carefully rate their response on a 5-point Likert scale, ranging from 'not at all' to 'extremely'.

    conducted at baseline and at week 8 (study's end)

  • Trail Making Test

    The TMT consists of two iterations - versions A and B - and brief samples of each will be provided for the participant to practice prior to the longer, scored version. This is a timed paper and pencil test requiring the participant to connect a series of numbers and/or letters that are randomly arranged.

    conducted at baseline and at week 8 (study's end)

Study Arms (2)

spirulina capsules

EXPERIMENTAL

six capsules daily (totaling 3 g)

Other: Spirulina capsules

Placebo

PLACEBO COMPARATOR

Pea powder - 6 capsules daily

Other: Placebo

Interventions

active intervention

spirulina capsules
PlaceboOTHER

no active ingredient

Placebo

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • healthy adults
  • ages 18-65
  • no underlying chronic disease or acute conditions
  • no autoimmune conditions
  • do not consume alcohol in excess, smoke, use recreational drugs
  • does not follow restrictive diets
  • will be recruited from the ASU university campus.

You may not qualify if:

  • not have been clinically diagnosed with depression
  • not taking antidepressants, anxiety, or stress medications, or any other medications
  • drugs, or supplements that could influence mental capacities
  • not pregnant or breastfeeding
  • not a competitive athlete

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

850 PBC

Phoenix, Arizona, 85004, United States

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Carol Johnston, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a parallel arm, 8-week, randomized controlled study with an experimental arm and a control arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Senior Associate Dean

Study Record Dates

First Submitted

April 12, 2025

First Posted

April 20, 2025

Study Start

April 15, 2025

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

August 19, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

We do not plan to publish in ICMJE journals

Locations